Study title: An open, uncontrolled study with 3 periods, each of 3 weeks duration to assess the clinical efficacy of budesonide via nebilizer, 1000 mg bid, in chronically weezing infants, aged 2 to 12 months, and to evaluate any adrenal side-effects .
| Type of medicine: Medicines containing chemical active substances | |||||
| Therapeutic area: Respiratory Tract Diseases [C08] | |||||
| Brands: Please see report | |||||
| MAH holders: Please see report | |||||
| Assessment: | |||||
| Active substance: BUDESONIDE | |||||
| ATC code: | |||||
| Document link: | |||||
| Document date: 2014-10-16 | |||||
| Study number: 04-2215 | |||||
| EudraCT number: | |||||
| Scope of study: Clinical | |||||
| Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
| - | - | Y | - | - | |